Familiar Therapeutics
Agent48Agent Readiness: 48/100. Above median. Measured by StartupHub.ai. Median 41.Trust74Data Trust: 74/100. Above median. Measured by StartupHub.ai. Median 61.Familiar Therapeutics translates proven human medicines into novel therapeutics and companion diagnostics for dogs and cats.
About
Familiar Therapeutics is a biotechnology company that aims to bring advances in modern human medicine to companion animals. They license veterinary rights to drugs with established human research, then lead the clinical development and regulatory work required for FDA approval in dogs and cats. The company focuses on developing treatments for serious diseases in pets, such as cancer, neurological disorders, and immune-mediated conditions.
Key facts
At-a-glance profile data
- Website
- familiartx.com
- Headquarters
- Redwood City, United States
- Founded
- 2026
- Employees
- 22
- Total funding
- $5M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 22 Oct 2026 | Seed | $5M | Pioneer Fund, Icehouse Ventures |
Tech stack
Detected on familiartx.com, last scanned 23 Oct 2026. Run your own scan
- Frontend
- Tailwind CSS, Bootstrap
- CMS / Builders
- Lovable
- CDN
- Cloudflare
- Email provider
- Google Workspace
Frequently asked
Is Familiar Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Familiar Therapeutics is 74 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Familiar Therapeutics raised?
Familiar Therapeutics has raised a total of $5M in funding. The most recent round on record is Seed.
How many employees does Familiar Therapeutics have?
Familiar Therapeutics has approximately 22 people on record.
